The vitamin A-related retinoids have recently been shown to be involved in the development of the central nervous system, both in specifying position along the head-to-tail axis and in the development of a specific subset of motor neurons.
How is it that we have lots of motor neurons of the right types and in the right places in the spinal cord to innervate our limbs? This difficult question has been the subject of neurobiological research since the last century. Progress in answering the question has not been notably rapid, but now three recent papers [1] [2] [3] have reported definite progress, with results that emphasise the role that retinoic acid -the biologically active vitamin A derivative -plays in specifying positional identity along the head-to-tail axis of the central nervous system (CNS) and determining motor neuron character in the spinal cord.
Retinoic acid and the Hox code
In vertebrates, the familiar homeobox genes of the four Hox clusters play a crucial role in informing cells of their position along the head-to-tail axis of both the neural tube and the adjacent mesoderm. The overlapping expression domains of these genes are thought to generate a 'Hox code' [4] that specifies positional identity ( Figure 1 ). This notion is supported by the results of experiments involving loss-of-function Hox mutations or overexpression of Hox genes in the mouse; these alterations have been found to result in transformations of the identity of both vertebrae, which develop from somites, and the segments of the hindbrain (known as rhombomeres). But what establishes the Hox code?
Several observations have pointed to retinoic acid as a key regulator of Hox gene expression. When embryos develop in either the absence of retinoic acid or the presence of excess retinoic acid, then the Hox code and the resulting anatomy are radically altered [5, 6] . Furthermore, the upstream control regions of several Hox genes, notably those expressed in the developing hindbrain, have been shown to possess retinoic acid response elements (RAREs, see below). Before considering the new evidence that retinoic acid plays an important part in specifying positional identity in the spinal cord, it is worth reviewing what we know about the biochemistry and biological action of retinoic acid.
Retinoic acid is derived from retinol (vitamin A) by oxidation, first to retinaldehyde by a retinol dehydrogenase and then to retinoic acid by a retinal dehydrogenase (RALDH). Retinoic acid exists in various forms: alltrans-retinoic acid, 9-cis-retinoic acid and 4-oxo-retinoic acid are the most common ones. The molecule acts at the level of the nucleus by binding to retinoic acid receptors, which are nuclear transcription factors. Two classes of retinoic acid receptor have been identified: the RARs -RARα, RARβ and RARγ -bind either all-trans-retinoic acid or 9-cis-retinoic acid, whereas the RXRs -RXRα, RXRβ and RXRγ -bind only 9-cis-retinoic acid. The RARs and RXRs act on retinoic-acid-responsive genes by heterodimerizing and binding to specific upstream sequences -the above-mentioned RAREs -thereby activating (or repressing) transcription. Different genes have slightly different RAREs, and the binding of different receptor heterodimers to different RAREs generates specificity. All of these players appear in the papers highlighted here [1] [2] [3] .
Where does retinoic acid come from in the embryo?
In addition to retinoic acid, two other manipulations have been shown to alter the Hox code of the developing hindbrain. One manipulation involves the grafting of somites next to the developing hindbrain neuroepithelium [7] , and the other involves the grafting of the hindbrain neuroepithelium itself to a more posterior location [8] .
Experiments of the latter type have suggested that there is a source of retinoic acid in the spinal cord which diffuses anteriorly into the hindbrain to set up the Hox code there [8] . The former type of experiment has now been taken further by Gould et al. [1] , using the Hoxb4 gene as an analytical marker. Hoxb4 has an early expression boundary in the posterior hindbrain, at the level of rhombomere 6/7, which is opposite somite 1. The control regions of Hoxb4 include an early neural enhancer containing an RARE; mutations in this RARE abolished the normal sites of Hoxb4 expression, demonstrating the importance of a source of endogenous retinoic acid. But where does the retinoic acid come from to set up the domain of early Hoxb4 expression?
This was investigated by culturing pieces of embryonic tissue from a transgenic line expressing a marker gene under the control of the Hoxb4 early neural enhancer. Normal expression was found to begin at somite stages 9/10, but when the presumptive hindbrain neuroepithelium from these early somite stages was cultured in isolation transgene expression failed to occur. When the same neuroepithelium was cultured with somites 2-5, which it would neighbour in the intact mouse, normal expression occurred. More posterior somites were found to work even better. This somite-derived inducing signal could be mimicked by retinoic acid and prevented by prior treatment of the somites with an inhibitor of retinoic acid synthesis, making retinoic acid an excellent candidate for being the inducing molecule. Transfilter experiments showed that the inducing factor actually had a molecular weight of 10-200 kDa, suggesting that either the retinoic acid is bound to a higher molecular weight factor that acts as a kind of chaperone, or that the high-molecular weight factor is downstream of the primary inducer.
Most amazingly, Gould et al. [1] also demonstrated that RAREs interpret positional information along the headto-tail axis. When the Hoxb4 RARE was swapped with the RARE from the Hoxb1 gene, which normally has a more anterior boundary of expression than Hoxb4, then the marker transgene was expressed in a wider domain, with a more anterior border resembling that of the endogenous Hoxb1 gene. This means that distinct RAREs can determine the positions along the head-totail axis of hindbrain Hox gene expression domains, and very likely other genes too.
The conclusion from this work was thus that the domains of Hox gene expression are established in the neuroepithelium by an inducer, the action of which involves retinoic acid and the source of which is in the adjacent mesoderm. This is precisely the same conclusion as has been reached by another set of recent studies, aimed at investigating a patterning event slightly further down the neural tube in the developing spinal cord, namely the positioning of the limb-specific motor neurons.
Motor neuron location and subtype
The limb-specific motor neurons are found at the brachial and lumbar levels of the neural tube, so that they can grow into the adjacent developing limb buds (Figure 2a ). This aspect of position is also related both to retinoic acid and the adjacent somites, exactly as in the case of the hindbrain described above. It is known that, at the brachial and lumbar enlargements, there are peaks of retinoic acid production [9, 10] , and that this is due to the presence in the motor neurons of an enzyme, RALDH-2, which makes retinoic acid [10, 11] . Ensini et al. [12] discovered that, when brachial (limb) level somites were moved posteriorly to thoracic (non-limb) levels, then ectopic limb-specific motor neurons were induced (Figure 2b ).
Sockanathan and Jessell [2] have now reported that cultured thoracic cord could be induced to produce these same limb-specific motor neurons by the addition of retinoic acid. Thus, again, retinoic acid and somites share the property of inducing changes in the neuroepithelium of the CNS. Sockanathan and Jessell [2] have gone further, however, in investigating the precise role of retinoic acid in the generation of a subset of motor neurons.
There are several subtypes of motor neuron. Medial motor cells (MMCs) extend the whole length of the spinal cord and innervate the muscles of the back and the ventral body wall, whereas lateral motor cells (LMCs) are found only at limb levels in the brachial and lumbar cord (Figure 2c ). Further, there are two classes of LMCs, those found medially (LMC m ), which innervate ventral limb muscles, and those found laterally (LMC l ), which innervate dorsal limb muscles (Figure 2c ). Each of these classes have previously been found to express a characteristic combination of LIM homeobox genes -forming a kind of 'LIM code' analogous to the Hox code mentioned above -and they can therefore be identified with certainty [13, 14] .
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Sockanathan and Jessell [2] have confirmed that it is the LMCs -both LMCLs and LMCMs -that express RALDH-2, and that in the thoracic cord, which does not generate LMCs, no RALDH-2 is expressed. This is clearly a crucial decision, with regard to positional identity along the head-to-tail axis, for the following reasons. When brachial explants were cultured in retinoic acid or retinol, the number of motor neurons was increased; more importantly, this was also observed when thoracic explants were cultured in retinoic acid.
But it was the type of motor neuron induced in these experiments that was the key finding. When brachial explants were cultured in the absence of retinoids, motor neurons were still produced, but none were LMCLs. In the presence of retinol or retinoic acid, however, LMCLs are produced. Most importantly, thoracic explants -from non-limb levels that normally have no LMCs -could also be induced to produce LMCLs in the presence of retinoic acid. The presence of retinoic acid at limb levels is thus the determining factor in the generation of the appropriate LMCs. This conclusion was reinforced by retrovirally misexpressing RALDH-2 in the thoracic cord, which induced ectopic motor neurons expressing the 'LIM code-word' for LMCL.
Two important findings came from a closer look at the RALDH-2 and LIM gene expression patterns. Firstly, some later-born cells expressing the LIM code-word for LMCL were found medial to the lateral motor columns, and these did not express RALDH-2. Sockanathan and Jessell [2] thus suggest that becoming a LMCL neuron is not a cell autonomous action, but involves retinoic acid signalling from earlier-born cells that express RALDH-2. Secondly, in the RALDH-2-transfected thoracic cords, most LMCL neurons did not themselves express RALDH-2, so they must have been induced by adjacent transfected cells. These observations suggest that the RALDH-2-expressing cells are the sites of retinoic acid production and act in a paracrine manner to influence the developmental fate of neighbouring cells.
As in most developmental studies, these observations emphasise the positive nature of signalling molecules, but they also immediately pose the question of what stops all cells from being positively affected by the signal. Specifically, why do not all LMCs become LMCLs once retinoic acid starts to be generated? Presumaby, LMCMs express something that prevents them from being affected by the surrounding retinoic acid, and the nature of such a putative inhibitor is an issue for the future.
Which retinoid receptors?
In any biological system where retinoic acid is involved, we need to know the mechanism of action and thus which of the many retinoid receptors are involved, and motor neuron development is no exception. As explained above, there are two classes of retinoid receptors that bind to the RAREs of retinoic-acid-responsive genes: the RARs and RXRs. These receptors function as homodimers or heterodimers. The RARs act as heterodimers with an RXR, whereas the RXRs can act as either homodimers or heterodimers with RARs or a range of other, related receptors. It is important to consider whether both partners of a heterodimer need to be liganded before the complex can be activated. In vitro, the RXR can act as a silent (unliganded) partner [15] and the endogenous ligand for the RXRs, 9-cis-retinoic acid, has not been found in chick or mouse embryos, whereas alltrans-retinoic acid is readily detectable.
A common approach to this question is to use receptorspecific agonists, to see whether simultaneous ligand activation of RARs and RXRs results in the synergistic promotion of a physiological response. Solomin et al. [3] , however, took a completely novel approach to demonstrating ligand activation of the receptors in vivo, with results that again pointed to motor neurons. They made two effector constructs consisting of the ligand-binding domain of either the RAR or the RXR fused to the yeast transcription factor GAL4; the constructs were inserted into a nestin expression vector, from which the fusion proteins could be expressed specifically in the CNS of transgenic mice. The authors also made a reporter construct, to indicate where the retinoic acid receptors are active in the transgenic mice, and, by inference, where ligand is present at high enough concentration to activate the receptors. The reporter construct consisted of the LacZ gene, a promoter and GAL4-specific binding sites. Thus, in the presence of the RAR or RXR ligand, GAL4 will be made from the effector construct, which will activate the reporter construct and make β-galactosidase which can be visualised.
Solomin et al. [3] found that the RAR construct was activated by day 10.5 of mouse embryogenesis in two now familiar locations, the brachial and lumbar spinal cord, where the forelimbs and hindlimbs were growing out. The RXR construct was activated slightly later, by day 11, and in precisely the same locations. Sections through the embryos showed RAR activation to begin in the ventral half of the neural tube, encompassing the developing motor neurons, and then move dorsally. The pattern of RXR activation was precisely the same, but half a day later. This time delay means that, by the time the RXR is activated in the motor neurons, activation of the RAR has already moved dorsally. These observations have two important implications: first, that the RXR is unlikely to act through RAR-RXR heterodimers, but rather through another pathway with another heterodimerisation partner; and second, that there are two waves of retinoid activity during motor neuron development.
Prospects
The recent results reviewed above made a clear case that retinoic acid is involved in positioning domains of gene expression along the head-to-tail axis of the embryo, and in the development of a specific subset of motor neurons. It will be fascinating in the future to learn whether there is a continuing requirement for retinoic acid in the maintenance of subsets of neurons, and whether its absence might play a role in the onset of neurodegenerative diseases, such as motor neuron disease.
